HomeHealthIndia among top 10 countries with two-thirds of hepatitis B & C...

India among top 10 countries with two-thirds of hepatitis B & C burden: WHO

New Delhi, April 9 (IANS) India is among the top 10 countries of the world that represent nearly two-thirds of the burden of hepatitis B and C combined, according to the World Health Organization (WHO) 2024 Global Hepatitis Report released on Tuesday.

The 10 countries are China, India, Indonesia, Nigeria, Pakistan, Ethiopia, Bangladesh, Vietnam, Philippines and the Russian Federation.

Of these three countries — China, India, and Indonesia — represented 50 per cent of the global burden in 2022 for hepatitis B. These were followed by Nigeria, Ethiopia, Bangladesh, Vietnam, Philippines and Pakistan.

The data from 187 countries released at the World Hepatitis Summit, showed that six countries — China, India, Indonesia, Pakistan, the Russian Federation, and the US — represented 50 per cent of the global burden for hepatitis C. These were followed by Ukraine, Uzbekistan, Bangladesh, Vietnam, Ethiopia, Mexico, Brazil, and Malaysia.

“Progress in these countries is critical to the global response,” the report said.

Further, the report noted that viral hepatitis infections are rising globally and claim about 3,500 lives each day, translating to about 1.3 million deaths per year. It is the second leading cause of death worldwide after tuberculosis.

From 1.1 million in 2019, the estimated number of deaths from viral hepatitis rose to 1.3 million in 2022. Of these, hepatitis B accounted for 83 per cent of deaths, while hepatitis C was responsible for 17 per cent of deaths.

“This report paints a troubling picture: despite progress globally in preventing hepatitis infections, deaths are rising because far too few people with hepatitis are being diagnosed and treated,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus, in a statement.

“WHO is committed to supporting countries to use all the tools at their disposal – at access prices – to save lives and turn this trend around,” he added.

The report noted that despite the availability of affordable generic viral hepatitis medicines, many countries fail to procure them at these lower prices.

It also recommended expanding access to testing and diagnostics, strengthening primary care prevention efforts, and using improved data for action.

–IANS

rvt/dan

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

RELATED ARTICLES
- Advertisment -

Most Popular